Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells

Kidney International

Volumn 53, Issue 4, 1998, Pages 1014-1021

  Douma, Caroline E ^a   Hiralall, Johan K ^b   De Waart, Dirk R ^b   Strulik, Dirk G ^b   Krediet, Raymond T ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

Dialysate plasma ratio; Icodextrin; Nitric oxide; Nitroprusside; Protein clearance; Ultrafiltration

Indexed keywords

ALBUMIN; ALPHA 2 MACROGLOBULIN; BETA 2 MICROGLOBULIN; CREATININE; CYCLIC GMP; DEXTRAN; DEXTRAN 70; DIALYSIS FLUID; ICODEXTRIN; IMMUNOGLOBULIN G; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PLASMA PROTEIN; UNCLASSIFIED DRUG; URATE; UREA;

ADULT; AGED; ARTICLE; CLEARANCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSATE; HUMAN; LYMPHATIC SYSTEM; MEMBRANE PERMEABILITY; MOLECULAR WEIGHT; PERITONEUM; PRIORITY JOURNAL; ULTRAFILTRATION;

EID: 0031970080     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.1998.00821.x     Document Type: Article

References (41)

1. WIDERÖE TE, SMEBY LC, MJÀLAND S, DAHL K, BERG KJ, WESSEL AAS T: Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis. Nephron 38:238-247, 1984
2. KREDIET RT, BOESCHOTEN EW, ZUYDERHOUDT FMJ, ARISZ, L: Peritoneal transport characteristics of water, low-molecular weight solutes and proteins during long-term continuous ambulatory peritoneal dialysis. Perit Dial Bull 6:61-65, 1986
3. VERGER C, LARPENT L, CELICOUT H: Clinical significance of ultrafiltration failure on CAPD, in Peritoneal Dialysis, edited by LA GRECA G, CHIARAMONTE S, FABRIS A, FELCIANI M, RONCO C, Milan, Wichtig Editore, 1986, pp 91-94
4. HEIMBÜRGER O, WANIEWSKI J, WERYNSKI A, TRANAEUS A, LINDHOLM B: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 38:495-506, 1990
5. IMHOLZ ALT, BROWN CB, KOOMEN GCM, ARISZ L, KREDIET RT: The effect of glucose polymers on water removal and protein clearances during CAPD. Adv Perit Dial 9:25-30, 1993
6. MISTRY CD, MALLICK NP, GOKAL R: The advantage of glucose polymer as an osmotic agent in continuous peritoneal dialysis. Proc EDTA-ERA 22:415-420, 1985
7. MISTRY CD, GOKAL R, PEERS E, MIDAS STUDY GROUP: A randomized multicenter trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 46:496-503, 1994
8. HO-DAC-PANNEKEET MM, SCHOUTEN N, LANGEDIJK MJ, HIRALALL JK, DE WAART DR, STRUIJK DG, KREDIET RT: Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 50: 979-986, 1996
9. GOKAL R, MISTRY CD, PEERS E, MIDAS STUDY GROUP: Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. Perit Dial Int 15:226-230, 1995
10. GRUETTER CA, GRUETTER DY, LYON JE, KADOWITZ PJ, IGNARRO LJ: Relationship between cyclic guanosine 3,5-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrate and nitrate oxide: Effects of methylene blue and methemoglobin. J Pharmacol Exp Ther 219:181-186, 1981
11. KELM M, SCHRADER J: Control of coronary vascular tone by nitric oxide. Circ Res 66:1561-1575, 1990
12. KOSAKA H, IMAIZUMI K, IMAI K, TYUMA I: Stoichiometry of the reaction of oxyhemoglobin with nitrite. Biochim Biophys Acta 5811: 184-188, 1979
13. NOLPH KD, GHODS AJ, BROWN PA, MILLER FN, HARRIS P, PYLE K, POPOVICH R: Effects of nitroprusside on peritoneal mass transfer coefficients and microvascular physiology. ASAIO Trans 23:210-218, 1977
14. MILLLR FN, JOSHUA IG, HARRIS PD, WIEGMAN DL, JAUCHEM JR: Peritoneal dialysis solutions and the microcirculation. Contrib Nephrol 17:51-58, 1979
15. DOUMA CE, DE WAART DR, STRUIJK DG, KREDIET RT: The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD. Kidney Int 51:1885-1892, 1997
16. PANNEKEET MM, IMHOLZ ALT, STRUIJK DG, KOOMEN GCM, LANGEDIJK MJ, SCHOUTEN N, DE WAART DR, HIRALALL JK, KREDIET RT: The standard peritoneal permeability analysis: A tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 48:866-875, 1995
17. KREDIET RT, STRUIJK DG, KOOMEN GCM, ARISZ L: Peritoneal fluid kinetics during CAPD measured with intraperitoneal dextran 70. ASAIO Trans 37:662-667, 1991
18. RENCK H, LJUNGSTRÖM HG, HEDIN H, RICHTER W: Prevention of dextran induced anaphylactic reaction by hapteen inhibition. Acta Chir Scan 149:355-360, 1983
19. KOOMEN GCM, KREDIET RT, LEEGWATER ACJ, STRUIJK DG, ARISZ L, HOEK FJ: A fast reliable method for the measurement of intraperitoneal dextran 70, used to calculate lymphatic absorption. Adv Perit Dial 7:10-14, 1991
20. STEGEMAN G, DE WAART DR, HIRALALL JK, KREDIET RT, ARISZ L, HOEK FJ: Measurement of dextran 70 in peritoneal dialysate containing icodextrin. (abstract) Perit Dial Int 15(Suppl 2):S18, 1995
21. IMHOLZ ALT, KOOMEN GCM, STRUIJK DG, ARISZ L, KREDIET RT: Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD. Kidney Int 43:1339-1346, 1993
22. WANIEWSKI J, WERYNSKI A, HEIMBÜRGER O, LINDHOLM B: Simple models for description of small-solute transport in peritoneal dialysis. Blood Purif 9:129-141, 1991
23. WANIEWSKI J, HEIMBÜRGER O, WERYNSKI A, LINDHOLM B: Aqueous solute concentrations and evaluation of mass transport coefficients in peritoneal dialysis. Nephrol Dial Transplant 7:50-56, 1992
24. HART O: Water balance; transport of fluids and solutes, in Human Physiology, edited by SCHMIDT RF, THEWS G, Berlin, Springer-Verlag, 1983, pp 653-654
25. ZEMEL D, KREDIET RT, KOOMEN GCM, STRUIJK DG, ARISZ L: Day-to-day variability of protein transport used as a method for analyzing peritoneal permeability in CAPD. Perit Dial Int 11:217-233, 1991
26. KREDIET RT, ZEMEL D, IMHOLZ ALT, STRUIJK DG: Impact of surface area and permeability on solute clearances. Perit Dial Int 14(Suppl 3):S70-S77, 1994
27. REDDINGIUS RE, SCHRÖDER CH, DAHA MR, WILLEMS JL, KOSTER AM, MONNENS LAH: Complement in serum and dialysate in children on continuous ambulatory peritoneal dialysis. Perit Dial Int 15:49-53, 1995
28. HO-DAC-PANNEKEET MM, ATASEVER B, STRUIJK DG, KREDIET RT: Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Perit Dial Int 17:144-150, 1997
29. DOUMA CE, DE WAART DR, STRUIJK DG, KREDIET RT: Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: A potential role for nitric oxide? Clin Nephrol 45:295-302, 1996
30. CANADA-USA (CANUSA) PERITONEAL DIALYSIS STUDY GROUP: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7:198-207, 1996
31. BLAKE P, BURKART JM, CHURCHILL DN, DAUGIRDAS J, DEPNER T, HAMBURGER RJ, HULL AR, KORBET SM, MORAN J, NOLPH KD, OREOPOULOS DG, SCHREIBNER M, SODERBLOOM R: Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 16:448-456, 1996
32. STRUIJK DG, KREDIET RT, KOOMEN GCM, HOEK FJ, BOESCHOTEN EW, VAN DER REIJDEN HJ, ARISZ L: Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis. Nephron 59:213-220, 1991
33. HO-DAC-PANNEKEET MM, KOOPMANS JG, STRUIJK DG, KREDIET RT: Restriction coefficients of low molecular weight solutes and macromolecules during peritoneal dialysis. Adv Peril Dial 13:17-22, 1997
34. PARK MS, LEE J, LEE MS, BAICK SH, HWANG SD, LEE HB: Peritoneal solute clearances after four years of continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 9:75-78, 1989
35. FOX J, GALEY F, WAYLAND H: Action of histamine on the mesenteric microvasculature. Microvasc Res 19:108-126, 1980
36. MILLER FN, JOSHUA IG, ANDERSON GL: Quantitation of vasodilator-induced macromolecular leakage by in vivo fluorescent microscopy. Microvasc Res 24:56-67, 1982
37. STYLIANOU E, JENNER LA, DAVIES M, COLES GA, WILLIAMS JD: Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 37:1563-1570, 1990
38. KREDIET RT, ZUYDERHOUDT FMJ, BOESCHOTEN EW, ARISZ L: Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients. Nephron 42:133-140, 1986
39. KAYSEN GA, SCHOENFELD PY: Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 25:107-114, 1984
40. BLAKE PG, FLOWERDEW G, BLAKE RM, OREOPOULOS DG: Serum albumin in patients on continuous ambulatory peritoneal dialysis -Predictors and correlations with outcomes. J Am Soc Nephrol 3:1501-1507, 1993
41. STRUIJK DG, KREDIET RT, KOOMEN GCM, BOESCHOTEN EW, ARISZ L: The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Perit Dial Int 14:121-126, 1994